Kalocyte
Baltimore
About Kalocyte
Kalocyte is a pre-clinical stage healthcare biotech startup company that provides artificial red blood cell substitutes used for trauma care related services. The company develops a demonstrated proof of concept for ErythroMer, a dried, bio-inspired artificial red blood cell envisioned for use when stored red blood cells are unavailable, undesirable, or in short supply. Kalocyte was founded in 2016 and is headquartered in Baltimore, Maryland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Grant (Aug 2023)
- Website: kalocyte.comwordpress
Industries & Categories
Biotechnology, Emergency Medicine, Health Care
Social Profiles
Canonical: https://fsome.com/organization/kalocyte-156242 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.